Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial

BACKGROUND: Patients with unprovoked (i.e., without the presence of apparent transient risk factors such as recent surgery) venous thromboembolism (VTE) are at risk of recurrence if anticoagulants are stopped after 3–6 months, yet their risk remains heterogeneous. Thus, prolonging anticoagulant trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Geersing, Geert-Jan, Hendriksen, Janneke M. T., Zuithoff, Nicolaas P. A., Roes, Kit C., Oudega, Ruud, Takada, Toshihiko, Schutgens, Roger E. G., Moons, Karel G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319277/
https://www.ncbi.nlm.nih.gov/pubmed/32589630
http://dx.doi.org/10.1371/journal.pmed.1003142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319277/
https://www.ncbi.nlm.nih.gov/pubmed/32589630
http://dx.doi.org/10.1371/journal.pmed.1003142

Ejemplares similares